Infective Endocarditis Prophylaxis for Cystoscopy After TAVR
Post-procedure antibiotic prophylaxis is not recommended for cystoscopy in patients with a prosthetic valve (including transcatheter valves) when no active infection is present. [1] This approach aligns with the 2023 ESC infective endocarditis prevention guidance for nondental procedures. [2]
Patient Risk Stratification for Prophylaxis
High-risk infective endocarditis populations include patients with prosthetic cardiac valves, including transcatheter-implanted prostheses. [1] Despite high baseline risk, antibiotic prophylaxis is not recommended for nondental procedures such as cystoscopy in the absence of active infection. [1]
Procedure-Specific Antibiotic Prophylaxis Indications
Antibiotic prophylaxis is recommended for dental procedures involving manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa. [1] Antibiotic prophylaxis is not recommended for nondental procedures such as cystoscopy when there is no active infection. [1]
Medication Selection Algorithm
Antibiotic prophylaxis should not be initiated solely for cystoscopy in the absence of infection. [1] No antibiotic regimen is indicated as prophylaxis for cystoscopy under this scenario. [1]
Monotherapy vs Combination Therapy
Antibiotic prophylaxis is not indicated, so monotherapy or combination prophylaxis does not apply. [1]
Initiation Thresholds and Indications
Prophylaxis is not recommended for cystoscopy in patients with valvular heart disease at high risk of infective endocarditis when active infection is absent. [1]
Common Pitfalls to Avoid
Routine prophylaxis for nondental procedures such as cystoscopy in the absence of infection is not recommended even in patients with prosthetic valves. [1]
Treatment Goals for Cystoscopy in This Scenario
Management should focus on avoiding active infection and maintaining aseptic technique rather than administering prophylactic antibiotics to prevent infective endocarditis. [1]